Cacace Angela M 4
4 · ARVINAS, INC. · Filed Feb 25, 2025
Insider Transaction Report
Form 4
ARVINAS, INC.ARVN
Cacace Angela M
Chief Scientific Officer
Transactions
- Sale
Common Stock
2025-02-24$16.75/sh−3,061$51,272→ 98,377 total - Sale
Common Stock
2025-02-24$16.55/sh−1,146$18,966→ 97,231 total
Footnotes (3)
- [F1]This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-half of the reporting person's restricted stock units (RSUs) granted on February 23, 2024.
- [F2]Includes an aggregate of 494 shares of the issuer's common stock purchased under and in accordance with the issuer's 2018 Employee Stock Purchaser Plan in transactions exempt under Rule 16b-3.
- [F3]This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-quarter of the reporting person's RSUs granted on February 22, 2023.